Theralase Technologies Valuation

Is TLT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of TLT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate TLT's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate TLT's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for TLT?

Key metric: As TLT barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for TLT. This is calculated by dividing TLT's market cap by their current book value.
What is TLT's PB Ratio?
PB Ratio	42.6x
Book	CA$1.66m
Market Cap	CA$68.13m

TLT key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	73.9x
Enterprise Value/EBITDA	-16x
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does TLT's PB Ratio compare to its peers?

The above table shows the PB ratio for TLT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	4x
ASG Aurora Spine	5x	n/a	CA$33.3m
NSCI Nanalysis Scientific	1.7x	n/a	CA$43.0m
PRN Profound Medical	6.1x	57.4%	CA$267.8m
PINK Perimeter Medical Imaging AI	3.4x	-10.2%	CA$56.0m
TLT Theralase Technologies	42.6x	71.9%	CA$68.1m

Price-To-Book vs Peers: TLT is expensive based on its Price-To-Book Ratio (42.6x) compared to the peer average (4x).

Price to Book Ratio vs Industry

How does TLT's PB Ratio compare vs other companies in the CA Medical Equipment Industry?

2 Companies	Price / Book	Estimated Growth	Market Cap
SCYB Scryb	0.4x	n/a	US$3.44m
ASEP ASEP Medical Holdings	0.3x	n/a	US$3.02m

No more companies available in this PB range

2 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Book vs Industry: TLT is expensive based on its Price-To-Book Ratio (42.6x) compared to the North American Medical Equipment industry average (2.5x).

Price to Book Ratio vs Fair Ratio

What is TLT's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

TLT PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	42.6x
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate TLT's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

NeuPath Health

CA$9.0m

Provides chronic pain management services in Canada.

NPTH

CA$0.17

6.3%

9.7%

Medical Facilities

CA$369.6m

Through its subsidiaries, owns and operates specialty hospitals and ambulatory surgery center in the United States.

CA$15.55

3.2%

79.1%

Carebook Technologies

CA$6.2m

Engages in the development and commercialization of digital health platforms for assessments, reporting, and targeted solutions in Canada, the United States, Europe, Latin America, Asia, and internationally.

CRBK

CA$0.05

-37.5%

-28.6%